Partner
Pharmaceuticals
CRISPR Therapeutics
Switzerland
Dr. Simeon George joined SR One in 2007 and leads SR One’s investment activities on the West Coast. Prior to joining SR One, Simeon was a consultant at Bain & Company and an investment banker at Goldman Sachs and Merrill Lynch. Simeon received his B.A. in neuroscience from the Johns Hopkins University, where he graduated Phi Beta Kappa. Simeon received his M.D. from the University of Pennsylvania School of Medicine and his M.B.A. (Mayer Scholar) from the University of Pennsylvania Wharton School.
Pharmaceutical Sciences